Sensus Healthcare, Inc., headquartered in the United States, is a leading innovator in the medical device industry, specialising in non-invasive treatments for skin cancer and other dermatological conditions. Founded in 2010, the company has made significant strides in advancing its core product line, which includes the Sensus SRT-100, a state-of-the-art superficial radiation therapy system. With a focus on patient-centric solutions, Sensus Healthcare has established a strong market position, particularly in North America, where it serves a diverse range of healthcare providers. The company is recognised for its commitment to quality and efficacy, making its products unique in the realm of skin cancer treatment. Notable achievements include expanding its operational reach and enhancing treatment accessibility, solidifying its reputation as a trusted partner in dermatology.
How does Sensus Healthcare, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Sensus Healthcare, Inc.'s score of 23 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sensus Healthcare, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Sensus Healthcare may not yet have established a comprehensive climate strategy or may be in the early stages of developing one. As the industry increasingly prioritises sustainability, it will be essential for Sensus Healthcare to consider implementing measurable climate initiatives and setting reduction targets to align with global standards and expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sensus Healthcare, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
